Share Price and Basic Stock Data
Last Updated: February 10, 2026, 8:31 pm
| PEG Ratio | 0.15 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bombay Burmah Trading Corporation Ltd operates in the Plantations sector, primarily focusing on tea and coffee. The company’s recent revenue trajectory indicates a positive trend, with reported sales rising from ₹14,507 Cr in FY 2022 to ₹16,623 Cr in FY 2023, and further to ₹17,109 Cr in FY 2024. The trailing twelve months (TTM) sales as of the latest reporting period stood at ₹18,858 Cr. Quarterly sales data shows fluctuations, with a notable peak of ₹4,943 Cr in September 2025. This suggests a robust demand for its products, partially driven by strategic operational efficiencies. The company has also recorded a consistent operating profit margin (OPM) around 19%, indicating effective cost management despite industry pressures. Overall, the revenue growth reflects the company’s adaptability and potential to leverage market opportunities, positioning it favorably against sector norms.
Profitability and Efficiency Metrics
Bombay Burmah reported a net profit of ₹2,276 Cr for the most recent fiscal year, showcasing a significant recovery from a net loss of ₹534 Cr in FY 2023. The earnings per share (EPS) improved remarkably to ₹160.90 in FY 2025, up from negative EPS of ₹240.22 the previous year. The company’s return on equity (ROE) stood at 21.9%, while the return on capital employed (ROCE) reached an impressive 35.5%, significantly higher than typical sector averages. The interest coverage ratio (ICR) of 21.50x indicates a strong ability to meet interest obligations, reflecting financial health. The cash conversion cycle (CCC) was reported at -6 days, indicating efficient management of working capital, as the company collects cash from sales faster than it pays its suppliers. These metrics illustrate a strong profitability framework and operational efficiency that positions Bombay Burmah favorably within its industry.
Balance Sheet Strength and Financial Ratios
The balance sheet of Bombay Burmah Trading Corporation reflects solid financial health, with total assets reported at ₹12,721 Cr and total liabilities at ₹12,721 Cr, indicating a balanced structure. The company holds ₹6,244 Cr in reserves, providing a buffer for operational flexibility and growth opportunities. Borrowings stood at ₹2,464 Cr, resulting in a low long-term debt to equity ratio of 0.12, which is favorable compared to industry standards. The price-to-book value (P/BV) ratio is reported at 2.19x, suggesting that the stock is trading at a premium relative to its book value, reflecting investor confidence. Additionally, the current ratio of 1.07 indicates adequate short-term liquidity. These financial ratios confirm that Bombay Burmah maintains a robust balance sheet, supporting its growth initiatives while managing financial risks effectively.
Shareholding Pattern and Investor Confidence
As of September 2025, the shareholding pattern of Bombay Burmah reveals a strong promoter presence at 74.05%, which enhances stability and long-term strategic direction. Foreign institutional investors (FIIs) hold 9.30% of the stock, while domestic institutional investors (DIIs) account for 1.43%. The public holds 15.22%, comprising approximately 44,643 shareholders. This distribution indicates a healthy mix of ownership that aligns with investor confidence, particularly given the significant promoter stake. The gradual increase in FII participation—from 7.82% in December 2022 to 9.30%—signals growing interest from foreign investors. However, the declining proportion of DIIs can be a point of concern, as it may indicate fluctuating confidence among domestic institutional investors. Overall, the shareholding structure reflects a generally positive sentiment towards the company’s future prospects.
Outlook, Risks, and Final Insight
Looking ahead, Bombay Burmah Trading Corporation has several strengths that could drive growth, including a solid financial position, strong profitability metrics, and effective operational efficiencies. However, risks remain, particularly in the form of market volatility and dependence on raw material prices, which can impact margins. The company’s ability to navigate changing consumer preferences and competitive pressures will be crucial. In a favorable scenario, continued revenue growth and operational efficiencies could enhance shareholder value further. Conversely, adverse market conditions or disruptions in supply chains could pose challenges. Ultimately, the company’s strategic initiatives and market adaptability will be pivotal in determining its future trajectory and maintaining investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 357 Cr. | 165 | 270/150 | 123 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 |
| Diana Tea Company Ltd | 42.1 Cr. | 28.1 | 42.0/23.3 | 47.3 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 142 Cr. | 158 | 185/126 | 14.1 | 223 | 0.95 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 10.0 Cr. | 15.9 | 15.9/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 123 Cr. | 398 | 639/350 | 13.2 | 528 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 8,850.47 Cr | 397.73 | 66.83 | 265.00 | 0.43% | 7.88% | 16.74% | 7.00 |
All Competitor Stocks of Bombay Burmah Trading Corporation Ltd
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,459 | 4,280 | 4,108 | 4,087 | 4,524 | 4,337 | 4,162 | 4,333 | 4,761 | 4,685 | 4,519 | 4,712 | 4,943 |
| Expenses | 4,056 | 3,756 | 3,431 | 3,748 | 3,737 | 3,538 | 3,399 | 3,598 | 4,037 | 3,811 | 3,717 | 3,988 | 4,007 |
| Operating Profit | 403 | 524 | 678 | 339 | 787 | 799 | 763 | 736 | 724 | 873 | 802 | 724 | 936 |
| OPM % | 9% | 12% | 16% | 8% | 17% | 18% | 18% | 17% | 15% | 19% | 18% | 15% | 19% |
| Other Income | 118 | 483 | -1,532 | 97 | 66 | 269 | 105 | 29 | 187 | 81 | 109 | 74 | 85 |
| Interest | 112 | 110 | 113 | 127 | 155 | 53 | 29 | 31 | 37 | 51 | 39 | 34 | 41 |
| Depreciation | 55 | 61 | 69 | 74 | 75 | 81 | 84 | 77 | 80 | 86 | 84 | 86 | 89 |
| Profit before tax | 353 | 836 | -1,037 | 235 | 624 | 934 | 756 | 656 | 794 | 818 | 788 | 678 | 891 |
| Tax % | 49% | 26% | 29% | 71% | 34% | 22% | 27% | 28% | 35% | 23% | 26% | 27% | 36% |
| Net Profit | 181 | 618 | -1,334 | 68 | 412 | 731 | 549 | 472 | 516 | 627 | 585 | 498 | 566 |
| EPS in Rs | -8.63 | 22.60 | -230.58 | -22.38 | 17.49 | 65.46 | 40.73 | 31.86 | 36.22 | 48.58 | 44.24 | 34.50 | 34.64 |
Last Updated: January 2, 2026, 5:01 am
Below is a detailed analysis of the quarterly data for Bombay Burmah Trading Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 4,943.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,712.00 Cr. (Jun 2025) to 4,943.00 Cr., marking an increase of 231.00 Cr..
- For Expenses, as of Sep 2025, the value is 4,007.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,988.00 Cr. (Jun 2025) to 4,007.00 Cr., marking an increase of 19.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 936.00 Cr.. The value appears strong and on an upward trend. It has increased from 724.00 Cr. (Jun 2025) to 936.00 Cr., marking an increase of 212.00 Cr..
- For OPM %, as of Sep 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Jun 2025) to 19.00%, marking an increase of 4.00%.
- For Other Income, as of Sep 2025, the value is 85.00 Cr.. The value appears strong and on an upward trend. It has increased from 74.00 Cr. (Jun 2025) to 85.00 Cr., marking an increase of 11.00 Cr..
- For Interest, as of Sep 2025, the value is 41.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.00 Cr. (Jun 2025) to 41.00 Cr., marking an increase of 7.00 Cr..
- For Depreciation, as of Sep 2025, the value is 89.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 86.00 Cr. (Jun 2025) to 89.00 Cr., marking an increase of 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 891.00 Cr.. The value appears strong and on an upward trend. It has increased from 678.00 Cr. (Jun 2025) to 891.00 Cr., marking an increase of 213.00 Cr..
- For Tax %, as of Sep 2025, the value is 36.00%. The value appears to be increasing, which may not be favorable. It has increased from 27.00% (Jun 2025) to 36.00%, marking an increase of 9.00%.
- For Net Profit, as of Sep 2025, the value is 566.00 Cr.. The value appears strong and on an upward trend. It has increased from 498.00 Cr. (Jun 2025) to 566.00 Cr., marking an increase of 68.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 34.64. The value appears strong and on an upward trend. It has increased from 34.50 (Jun 2025) to 34.64, marking an increase of 0.14.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:32 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,271 | 8,197 | 8,762 | 9,434 | 10,238 | 11,423 | 11,889 | 13,396 | 14,507 | 16,623 | 17,109 | 18,298 | 18,858 |
| Expenses | 6,642 | 7,335 | 7,558 | 8,164 | 8,919 | 9,741 | 10,138 | 11,247 | 12,912 | 14,897 | 14,242 | 15,162 | 15,522 |
| Operating Profit | 629 | 861 | 1,204 | 1,270 | 1,319 | 1,683 | 1,751 | 2,150 | 1,595 | 1,726 | 2,867 | 3,136 | 3,336 |
| OPM % | 9% | 11% | 14% | 13% | 13% | 15% | 15% | 16% | 11% | 10% | 17% | 17% | 18% |
| Other Income | 88 | 295 | 161 | 186 | 201 | 391 | 440 | 338 | 384 | -781 | 290 | 406 | 348 |
| Interest | 43 | 41 | 44 | 43 | 55 | 60 | 124 | 151 | 252 | 425 | 364 | 159 | 165 |
| Depreciation | 94 | 155 | 126 | 131 | 153 | 172 | 200 | 213 | 213 | 239 | 313 | 326 | 344 |
| Profit before tax | 579 | 961 | 1,195 | 1,282 | 1,312 | 1,841 | 1,868 | 2,124 | 1,514 | 281 | 2,479 | 3,057 | 3,175 |
| Tax % | 31% | 28% | 34% | 33% | 41% | 35% | 31% | 40% | 47% | 290% | 32% | 28% | |
| Net Profit | 402 | 696 | 792 | 858 | 773 | 1,189 | 1,280 | 1,278 | 809 | -534 | 1,689 | 2,199 | 2,276 |
| EPS in Rs | 29.68 | 51.15 | 55.36 | 60.45 | 39.76 | 89.00 | 85.75 | 52.96 | 9.09 | -240.22 | 91.24 | 160.90 | 161.96 |
| Dividend Payout % | 3% | 2% | 2% | 2% | 3% | 1% | 1% | 2% | 13% | -0% | 1% | 11% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 73.13% | 13.79% | 8.33% | -9.91% | 53.82% | 7.65% | -0.16% | -36.70% | -166.01% | 416.29% | 30.20% |
| Change in YoY Net Profit Growth (%) | 0.00% | -59.34% | -5.46% | -18.24% | 63.72% | -46.16% | -7.81% | -36.54% | -129.31% | 582.30% | -386.10% |
Bombay Burmah Trading Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 9% |
| 3 Years: | 8% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 14% |
| 3 Years: | 161% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 7% |
| 3 Years: | 27% |
| 1 Year: | -32% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -9% |
| 3 Years: | -19% |
| Last Year: | 22% |
Last Updated: September 5, 2025, 1:15 am
Balance Sheet
Last Updated: December 4, 2025, 1:03 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 1,280 | 1,552 | 1,899 | 3,664 | 3,950 | 4,403 | 5,080 | 5,462 | 5,483 | 4,018 | 4,614 | 5,618 | 6,244 |
| Borrowings | 787 | 883 | 793 | 1,014 | 1,024 | 956 | 2,045 | 2,670 | 5,880 | 6,542 | 2,161 | 1,574 | 2,464 |
| Other Liabilities | 1,601 | 2,043 | 2,442 | 2,699 | 3,344 | 4,054 | 4,190 | 4,271 | 3,874 | 5,103 | 5,121 | 5,515 | 5,472 |
| Total Liabilities | 3,682 | 4,493 | 5,148 | 7,391 | 8,332 | 9,427 | 11,329 | 12,418 | 15,251 | 15,677 | 11,911 | 12,721 | 14,193 |
| Fixed Assets | 1,875 | 1,878 | 1,989 | 2,217 | 2,373 | 2,717 | 2,889 | 2,802 | 2,763 | 3,638 | 3,751 | 3,880 | 3,889 |
| CWIP | 114 | 49 | 91 | 33 | 207 | 108 | 51 | 131 | 561 | 108 | 189 | 90 | 73 |
| Investments | 430 | 779 | 1,071 | 2,365 | 2,832 | 3,221 | 4,998 | 4,638 | 3,818 | 4,795 | 4,281 | 5,332 | 5,158 |
| Other Assets | 1,263 | 1,786 | 1,997 | 2,776 | 2,920 | 3,381 | 3,391 | 4,847 | 8,109 | 7,136 | 3,690 | 3,419 | 5,073 |
| Total Assets | 3,682 | 4,493 | 5,148 | 7,391 | 8,332 | 9,427 | 11,329 | 12,418 | 15,251 | 15,677 | 11,911 | 12,721 | 14,193 |
Below is a detailed analysis of the balance sheet data for Bombay Burmah Trading Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
- For Reserves, as of Sep 2025, the value is 6,244.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,618.00 Cr. (Mar 2025) to 6,244.00 Cr., marking an increase of 626.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,464.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,574.00 Cr. (Mar 2025) to 2,464.00 Cr., marking an increase of 890.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5,472.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5,515.00 Cr. (Mar 2025) to 5,472.00 Cr., marking a decrease of 43.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 14,193.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12,721.00 Cr. (Mar 2025) to 14,193.00 Cr., marking an increase of 1,472.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3,889.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,880.00 Cr. (Mar 2025) to 3,889.00 Cr., marking an increase of 9.00 Cr..
- For CWIP, as of Sep 2025, the value is 73.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2025) to 73.00 Cr., marking a decrease of 17.00 Cr..
- For Investments, as of Sep 2025, the value is 5,158.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,332.00 Cr. (Mar 2025) to 5,158.00 Cr., marking a decrease of 174.00 Cr..
- For Other Assets, as of Sep 2025, the value is 5,073.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,419.00 Cr. (Mar 2025) to 5,073.00 Cr., marking an increase of 1,654.00 Cr..
- For Total Assets, as of Sep 2025, the value is 14,193.00 Cr.. The value appears strong and on an upward trend. It has increased from 12,721.00 Cr. (Mar 2025) to 14,193.00 Cr., marking an increase of 1,472.00 Cr..
Notably, the Reserves (6,244.00 Cr.) exceed the Borrowings (2,464.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -158.00 | -22.00 | -792.00 | 0.00 | 0.00 | -955.00 | -1.00 | 0.00 | -4.00 | -5.00 | 0.00 | 2.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 9 | 10 | 9 | 13 | 15 | 11 | 9 | 10 | 9 | 10 | 10 |
| Inventory Days | 44 | 39 | 39 | 47 | 43 | 48 | 43 | 56 | 59 | 47 | 47 | 44 |
| Days Payable | 50 | 56 | 58 | 50 | 60 | 64 | 56 | 64 | 54 | 55 | 63 | 61 |
| Cash Conversion Cycle | 2 | -8 | -9 | 5 | -4 | -1 | -1 | 1 | 14 | 1 | -6 | -6 |
| Working Capital Days | -20 | -19 | -13 | 21 | 14 | 21 | -11 | -24 | -39 | -56 | -35 | -27 |
| ROCE % | 24% | 28% | 36% | 27% | 21% | 27% | 24% | 24% | 15% | 16% | 28% | 36% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Bandhan Small Cap Fund | 196,754 | 0.22 | 38.97 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 160.90 | 98.09 | -240.19 | 9.09 | 52.96 |
| Diluted EPS (Rs.) | 160.90 | 98.09 | -240.19 | 9.09 | 52.96 |
| Cash EPS (Rs.) | 340.69 | 320.35 | 109.37 | 234.88 | 251.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 807.16 | 952.73 | 832.81 | 973.01 | 1041.50 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 807.16 | 952.73 | 832.81 | 973.01 | 1041.50 |
| Revenue From Operations / Share (Rs.) | 2622.54 | 2450.67 | 2381.05 | 2083.31 | 1918.85 |
| PBDIT / Share (Rs.) | 487.98 | 501.00 | 464.05 | 370.66 | 394.29 |
| PBIT / Share (Rs.) | 441.18 | 456.12 | 429.77 | 339.89 | 363.82 |
| PBT / Share (Rs.) | 416.77 | 388.89 | 157.63 | 305.17 | 342.21 |
| Net Profit / Share (Rs.) | 293.89 | 275.46 | 75.10 | 204.11 | 220.95 |
| NP After MI And SOA / Share (Rs.) | 160.90 | 98.03 | -240.05 | 9.08 | 52.93 |
| PBDIT Margin (%) | 18.60 | 20.44 | 19.48 | 17.79 | 20.54 |
| PBIT Margin (%) | 16.82 | 18.61 | 18.04 | 16.31 | 18.96 |
| PBT Margin (%) | 15.89 | 15.86 | 6.62 | 14.64 | 17.83 |
| Net Profit Margin (%) | 11.20 | 11.24 | 3.15 | 9.79 | 11.51 |
| NP After MI And SOA Margin (%) | 6.13 | 4.00 | -10.08 | 0.43 | 2.75 |
| Return on Networth / Equity (%) | 19.93 | 14.63 | -41.54 | 1.15 | 6.74 |
| Return on Capital Employeed (%) | 35.48 | 41.37 | 29.15 | 22.59 | 29.71 |
| Return On Assets (%) | 8.82 | 5.72 | -10.64 | 0.41 | 2.97 |
| Long Term Debt / Equity (X) | 0.12 | 0.19 | 1.06 | 0.64 | 0.20 |
| Total Debt / Equity (X) | 0.27 | 0.45 | 1.62 | 1.07 | 0.48 |
| Asset Turnover Ratio (%) | 1.48 | 1.24 | 1.07 | 1.05 | 1.13 |
| Current Ratio (X) | 1.07 | 1.23 | 1.55 | 1.81 | 1.54 |
| Quick Ratio (X) | 0.75 | 0.93 | 1.32 | 1.51 | 1.24 |
| Inventory Turnover Ratio (X) | 14.35 | 6.93 | 6.27 | 5.80 | 6.53 |
| Dividend Payout Ratio (NP) (%) | 11.31 | 1.22 | -0.49 | 0.00 | 2.26 |
| Dividend Payout Ratio (CP) (%) | 8.76 | 0.83 | -0.58 | 0.00 | 1.43 |
| Earning Retention Ratio (%) | 88.69 | 98.78 | 100.49 | 0.00 | 97.74 |
| Cash Earning Retention Ratio (%) | 91.24 | 99.17 | 100.58 | 0.00 | 98.57 |
| Interest Coverage Ratio (X) | 21.50 | 9.61 | 7.63 | 10.28 | 18.32 |
| Interest Coverage Ratio (Post Tax) (X) | 14.02 | 6.58 | 5.15 | 6.63 | 11.27 |
| Enterprise Value (Cr.) | 15508.50 | 14170.57 | 10312.20 | 8595.21 | 10650.14 |
| EV / Net Operating Revenue (X) | 0.84 | 0.82 | 0.62 | 0.59 | 0.79 |
| EV / EBITDA (X) | 4.55 | 4.05 | 3.18 | 3.32 | 3.87 |
| MarketCap / Net Operating Revenue (X) | 0.67 | 0.63 | 0.34 | 0.41 | 0.57 |
| Retention Ratios (%) | 88.68 | 98.77 | 100.49 | 0.00 | 97.73 |
| Price / BV (X) | 2.19 | 2.34 | 1.41 | 1.09 | 1.42 |
| Price / Net Operating Revenue (X) | 0.67 | 0.63 | 0.34 | 0.41 | 0.57 |
| EarningsYield | 0.09 | 0.06 | -0.29 | 0.01 | 0.04 |
After reviewing the key financial ratios for Bombay Burmah Trading Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 160.90. This value is within the healthy range. It has increased from 98.09 (Mar 24) to 160.90, marking an increase of 62.81.
- For Diluted EPS (Rs.), as of Mar 25, the value is 160.90. This value is within the healthy range. It has increased from 98.09 (Mar 24) to 160.90, marking an increase of 62.81.
- For Cash EPS (Rs.), as of Mar 25, the value is 340.69. This value is within the healthy range. It has increased from 320.35 (Mar 24) to 340.69, marking an increase of 20.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 807.16. It has decreased from 952.73 (Mar 24) to 807.16, marking a decrease of 145.57.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 807.16. It has decreased from 952.73 (Mar 24) to 807.16, marking a decrease of 145.57.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,622.54. It has increased from 2,450.67 (Mar 24) to 2,622.54, marking an increase of 171.87.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 487.98. This value is within the healthy range. It has decreased from 501.00 (Mar 24) to 487.98, marking a decrease of 13.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 441.18. This value is within the healthy range. It has decreased from 456.12 (Mar 24) to 441.18, marking a decrease of 14.94.
- For PBT / Share (Rs.), as of Mar 25, the value is 416.77. This value is within the healthy range. It has increased from 388.89 (Mar 24) to 416.77, marking an increase of 27.88.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 293.89. This value is within the healthy range. It has increased from 275.46 (Mar 24) to 293.89, marking an increase of 18.43.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 160.90. This value is within the healthy range. It has increased from 98.03 (Mar 24) to 160.90, marking an increase of 62.87.
- For PBDIT Margin (%), as of Mar 25, the value is 18.60. This value is within the healthy range. It has decreased from 20.44 (Mar 24) to 18.60, marking a decrease of 1.84.
- For PBIT Margin (%), as of Mar 25, the value is 16.82. This value is within the healthy range. It has decreased from 18.61 (Mar 24) to 16.82, marking a decrease of 1.79.
- For PBT Margin (%), as of Mar 25, the value is 15.89. This value is within the healthy range. It has increased from 15.86 (Mar 24) to 15.89, marking an increase of 0.03.
- For Net Profit Margin (%), as of Mar 25, the value is 11.20. This value exceeds the healthy maximum of 10. It has decreased from 11.24 (Mar 24) to 11.20, marking a decrease of 0.04.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.13. This value is below the healthy minimum of 8. It has increased from 4.00 (Mar 24) to 6.13, marking an increase of 2.13.
- For Return on Networth / Equity (%), as of Mar 25, the value is 19.93. This value is within the healthy range. It has increased from 14.63 (Mar 24) to 19.93, marking an increase of 5.30.
- For Return on Capital Employeed (%), as of Mar 25, the value is 35.48. This value is within the healthy range. It has decreased from 41.37 (Mar 24) to 35.48, marking a decrease of 5.89.
- For Return On Assets (%), as of Mar 25, the value is 8.82. This value is within the healthy range. It has increased from 5.72 (Mar 24) to 8.82, marking an increase of 3.10.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 0.2. It has decreased from 0.19 (Mar 24) to 0.12, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has decreased from 0.45 (Mar 24) to 0.27, marking a decrease of 0.18.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.48. It has increased from 1.24 (Mar 24) to 1.48, marking an increase of 0.24.
- For Current Ratio (X), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 1.5. It has decreased from 1.23 (Mar 24) to 1.07, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has decreased from 0.93 (Mar 24) to 0.75, marking a decrease of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 14.35. This value exceeds the healthy maximum of 8. It has increased from 6.93 (Mar 24) to 14.35, marking an increase of 7.42.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.31. This value is below the healthy minimum of 20. It has increased from 1.22 (Mar 24) to 11.31, marking an increase of 10.09.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.76. This value is below the healthy minimum of 20. It has increased from 0.83 (Mar 24) to 8.76, marking an increase of 7.93.
- For Earning Retention Ratio (%), as of Mar 25, the value is 88.69. This value exceeds the healthy maximum of 70. It has decreased from 98.78 (Mar 24) to 88.69, marking a decrease of 10.09.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.24. This value exceeds the healthy maximum of 70. It has decreased from 99.17 (Mar 24) to 91.24, marking a decrease of 7.93.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 21.50. This value is within the healthy range. It has increased from 9.61 (Mar 24) to 21.50, marking an increase of 11.89.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 14.02. This value is within the healthy range. It has increased from 6.58 (Mar 24) to 14.02, marking an increase of 7.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 15,508.50. It has increased from 14,170.57 (Mar 24) to 15,508.50, marking an increase of 1,337.93.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.82 (Mar 24) to 0.84, marking an increase of 0.02.
- For EV / EBITDA (X), as of Mar 25, the value is 4.55. This value is below the healthy minimum of 5. It has increased from 4.05 (Mar 24) to 4.55, marking an increase of 0.50.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.67, marking an increase of 0.04.
- For Retention Ratios (%), as of Mar 25, the value is 88.68. This value exceeds the healthy maximum of 70. It has decreased from 98.77 (Mar 24) to 88.68, marking a decrease of 10.09.
- For Price / BV (X), as of Mar 25, the value is 2.19. This value is within the healthy range. It has decreased from 2.34 (Mar 24) to 2.19, marking a decrease of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.67, marking an increase of 0.04.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.09, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bombay Burmah Trading Corporation Ltd:
- Net Profit Margin: 11.2%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 35.48% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.93% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 14.02
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.75
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.3 (Industry average Stock P/E: 66.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.27
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.2%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | 9, Wallace Street, Fort, Mumbai Maharashtra 400001 | investorservices@bbtcl.com http://www.bbtcl.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nusli N Wadia | Chairman |
| Mr. Ness N Wadia | Managing Director |
| Mr. Jehangir N Wadia | Whole Time Director |
| Mr. Rajesh Batra | Director |
| Mr. Keki Manchersha Elavia | Director |
| Dr. Y S P Thorat | Director |
| Dr.(Mrs.) Minnie Bodhanwala | Director |
FAQ
What is the intrinsic value of Bombay Burmah Trading Corporation Ltd?
Bombay Burmah Trading Corporation Ltd's intrinsic value (as of 11 February 2026) is ₹3188.88 which is 76.57% higher the current market price of ₹1,806.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹12,603 Cr. market cap, FY2025-2026 high/low of ₹2,156/1,521, reserves of ₹6,244 Cr, and liabilities of ₹14,193 Cr.
What is the Market Cap of Bombay Burmah Trading Corporation Ltd?
The Market Cap of Bombay Burmah Trading Corporation Ltd is 12,603 Cr..
What is the current Stock Price of Bombay Burmah Trading Corporation Ltd as on 11 February 2026?
The current stock price of Bombay Burmah Trading Corporation Ltd as on 11 February 2026 is ₹1,806.
What is the High / Low of Bombay Burmah Trading Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bombay Burmah Trading Corporation Ltd stocks is ₹2,156/1,521.
What is the Stock P/E of Bombay Burmah Trading Corporation Ltd?
The Stock P/E of Bombay Burmah Trading Corporation Ltd is 11.3.
What is the Book Value of Bombay Burmah Trading Corporation Ltd?
The Book Value of Bombay Burmah Trading Corporation Ltd is 897.
What is the Dividend Yield of Bombay Burmah Trading Corporation Ltd?
The Dividend Yield of Bombay Burmah Trading Corporation Ltd is 0.94 %.
What is the ROCE of Bombay Burmah Trading Corporation Ltd?
The ROCE of Bombay Burmah Trading Corporation Ltd is 35.5 %.
What is the ROE of Bombay Burmah Trading Corporation Ltd?
The ROE of Bombay Burmah Trading Corporation Ltd is 21.9 %.
What is the Face Value of Bombay Burmah Trading Corporation Ltd?
The Face Value of Bombay Burmah Trading Corporation Ltd is 2.00.